Source: Eur Respir J 2014; 43: 1529-1530



Rating:

Share or cite this content

Citations should be made in the following way:
Troy Lauren, Glaspole Ian, Goh Nicole, Zappala Chris, Hopkins Peter, Wilsher Margaret, Moodley Yuben, Corte Tamera. Prevalence and prognosis of unclassifiable interstitial lung disease. Eur Respir J 2014; 43: 1529-1530

Member's Comments

No comment yet.

Related content which might interest you: Clinical characteristics of patients with unclassifiable interstitial lung disease Source: International Congress 2015 – New insights into IIPs Year: 2015 Comorbidities in unclassifiable interstitial lung disease Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Clusters of comorbidities in unclassifiable interstitial lung disease Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Progression of Rheumatoid-arthritis associated interstitial lung disease by radiological subtype Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers Year: 2018 Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Variation in mortality from interstitial lung disease by diagnosis Source: International Congress 2015 – IIPs: orphan Year: 2015 Interstitial lung disease: improving classification and prognosis Source: Virtual Congress 2021 – Clinical year in review Year: 2021 The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype Source: Eur Respir Rev, 27 (150) 180077; 10.1183/16000617.0077-2018 Year: 2018 Emphysema frequency in the cases who have interstitial lung disease diagnosis Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease Year: 2008 Treatment and prognosis of lung cancer associated with interstitial pneumonia Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series Year: 2010 The analysis of prognostic factors in patients with interstitial lung diseases Source: International Congress 2015 – New insights into IIPs Year: 2015 Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis Source: ERJ Open Res, 4 (1) 00111-2016; 10.1183/23120541.00111-2016 Year: 2018 Prevalence of progressive fibrosing interstitial lung disease Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 Prognostic factors of interstitial lung disease associated with primary Sjögren's syndrome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Using the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2015 – IIPs: orphan Year: 2015 Clinical characteristics of anti-Jo-1-positive interstitial lung disease Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019 The management of children with interstitial lung disease Source: International Congress 2018 – Difficult paediatric lung disease Year: 2018 Chronic obstructive pulmonary disease and interstitial lung disease could predict poor long-term survivals after pulmonary resection for lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 38s Year: 2002 The clinical value of surgical lung biopsy in 166 patients with suspected interstitial lung disease Source: International Congress 2015 – New insights into IIPs Year: 2015